Stocks · News reference
Catheter Precision, Inc. (VTAK: NYSE/American), today announced preliminary unaudited record revenues of $1,037,000 for the quarter ended June 30, 2026, including both the MedTech segment and the Flyte Vision Jet
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Key Commercial Highlights:Cardinal Health Strategic Reach: Catheter Precision received its first purchase order for LockeT via Cardinal Health. As one of the nation's largest distributors—servicing roughly 90% of
Read original at benzingaFlyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK) ("VTAK" or the "Company"), today announced that more than 10,000 consumer accounts are now registered on the Flyte WebApp, marking a
Read original at benzingaFiled: 2026-07-31 AccNo: 0001437749-26-025252 Size: 353 KB Item 3.02: Unregistered Sales of Equity Securities Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Read original at edgarForte Biosciences shares rose 38.9% to $76.10 in pre-market trading after argenx SE announced plans to acquire the company for $77 per share.
Read original at benzinga